Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision label was updated from Revision: v3.2.0 to Revision: v3.3.2. There are no visible changes to study details, eligibility criteria, or locations.SummaryDifference0.0%

- Check27 days agoChange DetectedThe notice about government funding status has been removed from the page; this change does not affect the study data or how a user would interact with the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedUpdated the trial site entry from 'Tainan City, Taiwan, 73657' to 'Tainan, Taiwan, 73657' to reflect the correct municipality name.SummaryDifference0.0%

- Check49 days agoChange DetectedThe two screenshots show the same study page with identical content; no additions, deletions, or updates to the study details or locations.SummaryDifference0.4%

- Check70 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%

- Check78 days agoChange DetectedUpdate: added a new contact-style number and new revision v3.1.0; removed old revision v3.0.2.SummaryDifference0.1%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.